Antisensebased drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer diabetes and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.